Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Claas Ulrich"'
Autor:
Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F. L. Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 7, Pp 1739-1753 (2024)
Abstract Actinic keratosis (AK) is an intraepithelial condition characterized by the development of scaly, erythematous lesions after repeated exposure to ultraviolet radiation. Significant immunosuppression is a risk factor for the development of AK
Externí odkaz:
https://doaj.org/article/d470f20101c54fcfa6420674c9d97c52
Autor:
Leonie Müller-Jensen, Samuel Knauss, Lorena Ginesta Roque, Christian Schinke, Smilla K. Maierhof, Frederik Bartels, Carsten Finke, Kristin Rentzsch, Claas Ulrich, Raphael Mohr, Werner Stenzel, Matthias Endres, Wolfgang Boehmerle, Petra Huehnchen
Publikováno v:
Data in Brief, Vol 53, Iss , Pp 110062- (2024)
The rise of cancer immunotherapy has been a milestone in clinical oncology. Above all, immune checkpoint inhibitor treatment (ICI) with monoclonal antibodies targeting programmed cell death protein 1 (PD-1), programmed cell death-ligand 1 (PD-L1), an
Externí odkaz:
https://doaj.org/article/6e49c5ff1fb645e0a9241cc6f88606f1
Autor:
Leonie Müller-Jensen, Samuel Knauss, Lorena Ginesta Roque, Christian Schinke, Smilla K. Maierhof, Frederik Bartels, Carsten Finke, Kristin Rentzsch, Claas Ulrich, Raphael Mohr, Werner Stenzel, Matthias Endres, Wolfgang Boehmerle, Petra Huehnchen
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundNeurological immune-related adverse events (irAE-n) are severe and potentially fatal toxicities of immune checkpoint inhibitors (ICI). To date, the clinical significance of neuronal autoantibodies in irAE-n is poorly understood. Here, we ch
Externí odkaz:
https://doaj.org/article/e63286da6f3c4d12b8bfb38bedfae241
Autor:
Duncan C. Miller, Pawel Lisowski, Selene Lickfett, Barbara Mlody, Miriam Bünning, Carolin Genehr, Claas Ulrich, Erich E. Wanker, Sebastian Diecke, Josef Priller, Alessandro Prigione
Publikováno v:
Stem Cell Research, Vol 65, Iss , Pp 102976- (2022)
Huntington’s disease (HD) is a neurodegenerative disorder caused by abnormal glutamine (Q) expansion in the huntingtin protein due to elongated CAG repeats in the gene HTT. We used non-integrative episomal plasmids to generate induced pluripotent s
Externí odkaz:
https://doaj.org/article/bb9f7998ccc941c989eb4b530769af6a
Autor:
Marc Rocholl, Patricia Weinert, Stephan Bielfeldt, Sabrina Laing, Klaus Peter Wilhelm, Claas Ulrich, Swen Malte John
Publikováno v:
Journal of Occupational Medicine and Toxicology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Outdoor workers (OW) are highly exposed to solar ultraviolet radiation (UVR) and thus at increased risk for developing skin cancer. An essential part of an overall strategy to reduce workplace UVR-exposure to OW’s skin is the us
Externí odkaz:
https://doaj.org/article/f0c19f0a03414aada8291947cefe7697
Autor:
Jiaqi Zhu, Bernd Gillissen, Dieu Linh Dang Tran, Stefanie May, Claas Ulrich, Eggert Stockfleth, Jürgen Eberle
Publikováno v:
Antioxidants, Vol 11, Iss 7, p 1416 (2022)
The term sinecatechins designates an extract containing a high percentage of catechins obtained from green tea, which is commercially registered as Veregen or Polyphenon E (PE) and may be considered for treatment of cutaneous squamous cell carcinoma
Externí odkaz:
https://doaj.org/article/0d580e18d7784a0ca242dc644fa24cbd
Autor:
Dirk Schadendorf, Ralf Gutzmer, Thomas Eigentler, Israel Lowy, Vladimir Jankovic, Elizabeth Stankevich, Anna C Pavlick, Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Nikhil I Khushalani, Brett G M Hughes, Lara A Dunn, Leonel Hernandez-Aya, Anne Lynn S Chang, Badri Modi, Axel Hauschild, Claas Ulrich, Brian Stein, Jessica L Geiger, Murad Alam, Emmanuel Okoye, Melissa Mathias, Jocelyn Booth, Siyu Li, Matthew G Fury, Alexander Guminski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Cemiplimab, a high-affinity, potent human immunoglobulin G4 monoclonal antibody to programmed cell death-1 demonstrated antitumor activity in a Phase 1 advanced cutaneous squamous cell carcinoma (CSCC) expansion cohort (NCT02383212) and th
Externí odkaz:
https://doaj.org/article/a6c7cd3cc4a44c238d9eeebc62a5df0f
Publikováno v:
Antioxidants, Vol 10, Iss 10, p 1514 (2021)
Efficient drugs are needed for countering the worldwide high incidence of cutaneous squamous cell carcinoma (cSCC) and actinic keratosis. Indirubin derivatives represent promising candidates, but their effects in cSCC cells have not been reported bef
Externí odkaz:
https://doaj.org/article/ef482de52d8843aaa119b0b6f3a415b6
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215379 (2019)
Non-melanoma-skin cancer is an emerging clinical problem in the elderly, fair skinned population which predominantly affects patients aged older than 70 years. Its steady increase in incidence rates and morbidity is paralleled by related medical cost
Externí odkaz:
https://doaj.org/article/eb0e868b00ac48ad98e2c13d5707f9a6
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0220488 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0215379.].
Externí odkaz:
https://doaj.org/article/b53bc54c6ba14190badc26065106f984